Literature DB >> 16887889

Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Martijn J Kikkert1, Aart H Schene, Maarten W J Koeter, Debbie Robson, Anja Born, Hedda Helm, Michela Nose, Claudia Goss, Graham Thornicroft, Richard J Gray.   

Abstract

One of the major clinical problems in the treatment of people with schizophrenia is suboptimal medication adherence. Most research focusing on determinants of nonadherence use quantitative research methods. These studies have some important limitations in exploring the decision-making process of patients concerning medication. In this study we explore factors influencing medication adherence behavior in people with schizophrenia using concept mapping. Concept mapping is a structured qualitative method and was performed in 4 European countries. Participants were 27 patients with schizophrenia, 29 carers, and 28 professionals of patients with schizophrenia. Five clinically relevant themes were identified that affect adherence: medication efficacy, external factors (such as patient support and therapeutic alliance), insight, side effects, and attitudes toward medication. Importance ratings of these factors differed significantly between professionals and carers and patients. Professionals, carers, and patients do not have a shared understanding of which factors are important in patients' medication adherence behavior. Adherence may be positively influenced if professionals focus on the positive aspects of medication, on enhancing insight, and on fostering a positive therapeutic relationship with patients and carers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887889      PMCID: PMC2632275          DOI: 10.1093/schbul/sbl011

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  42 in total

1.  Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses.

Authors:  D Turkington; D Kingdon
Journal:  Br J Psychiatry       Date:  2000-08       Impact factor: 9.319

2.  Priorities of consumers, providers, and family members in the treatment of schizophrenia.

Authors:  Ellen P Fischer; Martha Shumway; Richard R Owen
Journal:  Psychiatr Serv       Date:  2002-06       Impact factor: 3.084

3.  Predicting medication noncompliance after hospital discharge among patients with schizophrenia.

Authors:  M Olfson; D Mechanic; S Hansell; C A Boyer; J Walkup; P J Weiden
Journal:  Psychiatr Serv       Date:  2000-02       Impact factor: 3.084

Review 4.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Authors:  Jonathan P Lacro; Laura B Dunn; Christian R Dolder; Susan G Leckband; Dilip V Jeste
Journal:  J Clin Psychiatry       Date:  2002-10       Impact factor: 4.384

5.  Indicators of medication compliance in first-episode psychosis.

Authors:  Olli Kampman; Pekka Laippala; Juha Väänänen; Elina Koivisto; Päivi Kiviniemi; Nina Kilkku; Klaus Lehtinen
Journal:  Psychiatry Res       Date:  2002-05-15       Impact factor: 3.222

Review 6.  Compliance with antipsychotic treatment.

Authors:  M Oehl; M Hummer; W W Fleischhacker
Journal:  Acta Psychiatr Scand Suppl       Date:  2000

7.  Do clinicians understand why individuals stop taking lithium?

Authors:  Marie Pope; Jan Scott
Journal:  J Affect Disord       Date:  2003-05       Impact factor: 4.839

8.  Medication compliance in a Chinese psychiatric out-patient setting.

Authors:  D W Chan
Journal:  Br J Med Psychol       Date:  1984-03

9.  Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.

Authors:  Anita Holzinger; Watter Loffler; Peter Muller; Stefan Priebe; Matthias C Angermeyer
Journal:  J Nerv Ment Dis       Date:  2002-09       Impact factor: 2.254

Review 10.  From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication.

Authors:  R Gray; T Wykes; K Gournay
Journal:  J Psychiatr Ment Health Nurs       Date:  2002-06       Impact factor: 2.952

View more
  31 in total

1.  Using the theory of planned behavior to improve treatment adherence in Mexican Americans with schizophrenia.

Authors:  Alex Kopelowicz; Roberto Zarate; Charles J Wallace; Robert Paul Liberman; Steven R Lopez; Jim Mintz
Journal:  J Consult Clin Psychol       Date:  2015-06-01

2.  Impact of a Mental Illness Stigma Awareness Intervention on Pharmacy Student Attitudes and Knowledge.

Authors:  Benita A Bamgbade; Kentya H Ford; Jamie C Barner
Journal:  Am J Pharm Educ       Date:  2016-06-25       Impact factor: 2.047

3.  Shared decision making in mental health treatment: qualitative findings from stakeholder focus groups.

Authors:  Irma H Mahone; Sarah Farrell; Ivora Hinton; Robert Johnson; David Moody; Karen Rifkin; Kenneth Moore; Marcia Becker; Missy Rand Barker
Journal:  Arch Psychiatr Nurs       Date:  2011-06-11       Impact factor: 2.218

4.  A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia.

Authors:  John F P Bridges; Lara Slawik; Annette Schmeding; Jens Reimer; Dieter Naber; Olaf Kuhnigk
Journal:  Health Expect       Date:  2011-06-14       Impact factor: 3.377

5.  Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disorders.

Authors:  Lora Humphrey Beebe; Kathy Smith; Renee Burk; Kelly McIntyre; Olivera Dessieux; Abbas Tavakoli; Clif Tennison; Dawn Velligan
Journal:  Community Ment Health J       Date:  2010-11-27

6.  Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient-caregiver dyad perspective.

Authors:  Irene A Kretchy; Bernard Appiah; Kofi Agyabeng; Emmanuel M Kwarteng; Enyonam Ganyaglo; Grace Owusu Aboagye
Journal:  Int J Clin Pharm       Date:  2021-04-09

7.  Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies.

Authors:  J Volavka; R A Van Dorn; L Citrome; R S Kahn; W W Fleischhacker; P Czobor
Journal:  Eur Psychiatry       Date:  2015-12-04       Impact factor: 5.361

8.  Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders.

Authors:  Malin Alenius; Margareta Hammarlund-Udenaes; Per Hartvig; Leif Lindström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-21       Impact factor: 4.328

Review 9.  Improving treatment adherence in your patients with schizophrenia: the STAY initiative.

Authors:  Fernando Cañas; Koksal Alptekin; Jean Michel Azorin; Vincent Dubois; Robin Emsley; Antonio G García; Philip Gorwood; Peter M Haddad; Dieter Naber; José M Olivares; Georgios Papageorgiou; Miquel Roca
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

10.  Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

Authors:  Hong Liu-Seifert; David H Adams; Haya Ascher-Svanum; Douglas E Faries; Bruce J Kinon
Journal:  Patient Prefer Adherence       Date:  2007-12-20       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.